Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02098057 · ClinicalTrials.gov registry record · NA
Change in Permeability of the Small Intestine After Treatment With Gluten
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02098057: Completed NA study, sponsored by Mayo Clinic.
NCT02098057 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02098057, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The overall hypothesis of this research study is that gluten intake alters intestinal barrier function in patients with Irritable Bowel Syndrome (IBS) diarrhea who also exhibit non-celiac gluten sensitivity (NCGS).
Interventions
- DRUG Placebo
- DIETARY_SUPPLEMENT Gluten Healthy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-09-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02098057
The ClinicalTrials.gov registry entry for NCT02098057 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02098057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02098057 about?
NCT02098057 is a clinical study titled "Change in Permeability of the Small Intestine After Treatment With Gluten". The overall hypothesis of this research study is that gluten intake alters intestinal barrier function in patients with Irritable Bowel Syndrome (IBS) diarrhea who also exhibit non-celiac gluten sensitivity (NCGS).
What is the current status of trial NCT02098057?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2014-04. Estimated completion is 2016-09-19.
What interventions are being tested in trial NCT02098057?
The interventions under investigation include: Placebo (DRUG), Gluten Healthy (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02098057?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.